Zydus Wellness Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/rck0w5eugwm5g4xwnwkm6n5h.pdf

Key Takeaways


Topline & Volume Dynamics

Arora: "We are hopeful that we'll continue this double-digit journey and execute well on our existing brands as well as new product portfolio."

Segment Performance

SegmentTrendCommentary
Personal Care▲ StrongDouble-digit growth for 7 quarters; Everyuth and Nycil are market leaders; new products like Pink Clay and charcoal range gaining traction.
Food & Nutrition▬ MixedGlucon-D delivered double-digit growth over 3–4 years, targeting category expansion from ₹1,100 cr to ₹1,500 cr; Complan is a drag as a large, low-growth brand.
Sugar Free Green▲ StrongStrong double-digit growth driven by increasing volume uptake.
Nutralite▲ ImprovingContinued upward trajectory from digital and on-ground activations; launched AI-powered recipe platform.
NaturellEarly stageOne month of performance included post-acquisition; pre-acquisition margins were 3–5%, with synergy expected to lift them materially.

Margin Trajectory

Arora: "We do believe that there is still scope for us to continue. We believe our journey is still not completed where we have stabilized. It's still going to go up."

Seasonality & Profit Structure


New Initiatives & Digital Bets

Arora: "Prior to acquisition, we saw a 3% to 5% kind of margins, but with synergy and scale and our work with them, we obviously expect the margins to grow in -- to a much higher level. And we believe FY '26, we could have an EPS accretive on this business."

Competitive & Strategic Context


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthDouble-digit top-line growthFY26
EBITDA growthIn sync with or faster than top-line growthFY26
EBITDA margin17–18%Next 6–8 quarters
Naturell profitabilityEPS accretiveFY26
Effective tax rateShift to 21%FY27 onwards
Deferred tax liability~₹3.5–4 crores recorded in Q4Q4 FY25
Seasonal profit structure85–90% of profits in Q4 and Q1; no change expectedShort to medium term

Key Metrics

MetricQ3 FY25
Consolidated net sales₹450.8 cr, +12.7% YoY
Volume growth4.8% YoY
EBITDA₹14.8 cr, +16.5% YoY
Net profit after tax₹6.4 cr
Personal Care segment growth50.3% YoY
Food & Nutrition segment growth8.8% YoY
Gross marginSteady with slight upward trajectory both sequentially and YoY; October-December gross margins reasonably matched October-December 2021 levels
EBITDA margin trajectoryEBITDA growth faster than top-line growth for last 2 quarters; 9-month margin improvement of more than 200 bps largely from June quarter
Revenue from online platforms10% to 11% of total revenue
Food service (HoReCa) channel share8% to 10% of overall sales
Everyuth scrub market share47.3% in facial scrub category, +418 bps YoY at MAT level
Everyuth peel off market share77.8%, +106.7 bps YoY at MAT level
Nycil market share33.9% in prickly heat powder category, number one position at MAT level
Glucon-D market share58.9% in glucose powder category at MAT level
Sugar Free market share95.4% in sugar substitute category at MAT level
Complan market share4.1% in nutrition category at MAT level
Naturell (Ritebite) acquisition contributionLow single-digit share of top line, operated at breakeven EBITDA level
Deferred tax liability₹3.5 cr to ₹4 cr recorded in Q3, similar amount expected in Q4
Effective tax rate shift to 21%Expected from FY '27
FY26 guidanceDouble-digit growth on top line, EBITDA growth in sync or faster than top line growth